VidhyaKariveduMD

Oncology • Durham, NC

Head & Neck Cancer

Assistant Professor of Medicine

Join to view full profile

Dr. Karivedu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Karivedu's full profile

Already have an account?

Office
Duke Cancer Center
20 Duke Medicine Cir
Durham, NC 27710
Phone+1 919-862-5400

Education & Training

University of Cincinnati Medical Center/College of MedicineFellowship, Hematology and Medical Oncology, 2016 - 2019
Cleveland Clinic Foundation/Fairview HospitalChief Residency, Internal Medicine, 2015 - 2016
Cleveland Clinic Foundation/Fairview HospitalResidency, Internal Medicine, 2013 - 2016
Sri Venkatesvara Medical College NTRClass of 2011

Certifications & Licensure

FL State Medical License 2022 - 2025
NC State Medical License 2023 - 2025
OH State Medical License 2016 - 2024
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

32 citations
A review of optimal prostate biopsy: indications and techniques.
Justin Streicher, Brian Lee Meyerson, Vidhya Karivedu, Abhinav Sidana
Therapeutic Advances in Urology. 2019-08-28
5 citations
Association between Tumor Microbiome and Hypoxia across Anatomic Subsites of Head and Neck Cancers.
Aastha Dhakal, Rituraj Upadhyay, Caroline Wheeler, Rebecca Hoyd, Vidhya Karivedu
International Journal of Molecular Sciences. 2022-12-08
27 citations
Current Therapy for Metastatic Head and Neck Cancer: Evidence, Opportunities, and Challenges.
Trisha M Wise-Draper, Houda Bahig, Marion Tonneau, Vidhya Karivedu, Barbara Burtness
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2022-04-01

Lectures

Metformin treatment of locally advanced head and neck squamous cell carcinoma (LAHNSCC) patients induces an anti-tumorigenic immune response.
ASCO Annual Meeting 2019 - Chicago, IL - 6/1/2019

Press Mentions

University of Cincinnati Cancer Experts Present Research at ASCO Annual MeetingMay 25th, 2023